Biotechnology

Pieris Pharmaceuticals to Host Full-Year 2020 Investor Call and Provide Corporate Update on March 30, 2021

March 23, 2021 8:00 AM

BOSTON, MA / ACCESSWIRE / March 23, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory diseases, cancer and other indications, today announced that it will host a full-year 2020 investor call on Tuesday, March 30, 2021 at 8:00 AM EDT to discuss financial results and provide a corporate update. To access...

Read more

Lexaria to Present at the Benzinga Biotech Small Cap Conference on March 24, 2021 at 9:45 AM ET

March 23, 2021 7:00 AM

Lexaria recently announced progress on its hypertension R&D program, consisting of three human clinical and two animal studies, as well as two studies in its antiviral drug evaluation program KELOWNA, BC / ACCESSWIRE / March 23, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced that CEO Chris Bunka is presenting at the...

Read more

Bio Lab Naturals, Inc. a Delaware Corporation, (BLAB:OTC) Addresses a Yahoo Press Release Containing Information that was not Applicable to the Company

March 22, 2021 3:25 PM

DENVER, CO / ACCESSWIRE / March 22, 2021 / Bio Lab Naturals, Inc., a Delaware corporation, "BLAB" (OTCQB:BLAB) based in Denver, Colorado wishes to clear up any confusion as to a news release dated January 6, 2020, that appears on Yahoo Finance on the quote page for Bio Lab Naturals, Inc. ("BLAB" OTC). That news release related to a proposed transaction between Canavation, Inc. of Tampa, Florida, and Bio Lab Naturals, Inc. a Florida corporation,...

Read more

Molecular Partners Announces Intention to Conduct a Registered Offering in the United States

March 22, 2021 12:40 PM

ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / March 22, 2021 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company that is developing a new class of custom-built protein drugs known as DARPin® therapeutics, today announced that it plans to conduct a registered public offering of its ordinary shares, in the form of American Depositary Shares ("ADSs"), in the United States and has confidentially submitted a draft registration...

Read more

Wuhan Announces Opening Cape Town Office

March 22, 2021 9:15 AM

CAPE TOWN, SA / ACCESSWIRE / March 22, 2021 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) ("Wuhan'' or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to announce today that the Company has signed a lease on a new office in Cape Town's trendy Woodstock area. The move will take place this week and will enable the company's divisions, including food sciences, cosmetics,...

Read more

Edesa Biotech Expands Rights to Anti-Inflammatory Technology

March 22, 2021 7:45 AM

TORONTO, ON / ACCESSWIRE / March 22, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, announced today that it has entered into a definitive license agreement under which the company, through a subsidiary, has acquired additional global rights to a non-steroidal anti-inflammatory technology that forms the basis of the company's EB01 and EB02 drug...

Read more

OMNICANNA/Thermic Appoints Mr. Hendrik Schutte as Research Director of Electrical Components, Sales & Development (DECS), Renewable Thermic Solid State Battery Power Units and Thermic Self-Generating Electrical Power Units, International Sales & Distribution

March 19, 2021 8:20 AM

NASHVILLE, TN / ACCESSWIRE / March 19, 2021 / Thermic Sciences International, former known as Omnicanna Health Solutions, Inc. aka ENDOCAN CORP. (WKN: A1W61J, ISIN: US29271J1097, OTC PINK:ENDO), is pleased to announce the appointment of Mr. Hendrik Schutte as Research Director of Electrical Components, Sales & Development (DECS), as TSi moves forward with its Thermic technology and the new Electroluminescent Litcoat initiatives as the Thermic...

Read more

Havn Life CEO to Present at Zooming with LD, a Leading Platform for Microcap Companies

March 19, 2021 8:00 AM

CEO Tim Moore will appear on Tuesday, March 24th at 8:00 AM PT/ 11:00 AM ET VANCOUVER, BC / ACCESSWIRE / March 19, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the "Company" or "Havn Life"), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, announced today that it will be presenting virtually at the upcoming Zooming with LD event on...

Read more

Apollo Endosurgery Announces Inducement Grant

March 19, 2021 8:00 AM

AUSTIN, TX / ACCESSWIRE / March 19, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced the terms of equity awards granted to Chas McKhann in connection with his appointment as the company's CEO in March 2021. The company's board of directors granted Chas a stock option to purchase an aggregate of 848,733 shares of common stock,...

Read more

Modular Medical Establishes a Distinguished Multi-Disciplinary Advisory Board

March 18, 2021 9:00 AM

A group of prominent health care professionals and experts in the use and development of diabetes technology brings extensive insights across the spectrum of patient care SAN DIEGO, CA / ACCESSWIRE / March 18, 2021 / Modular Medical, Inc. (OTCQB: MODD), a development-stage company focused on making insulin delivery technology available to a greater number of people with insulin-requiring diabetes, today announced the formal establishment of...

Read more

Experion Announces Fiscal Year End and Q4 2020 Financial Reporting Release Date and Earnings Call

March 18, 2021 8:45 AM

VANCOUVER, BC / ACCESSWIRE / March 18, 2021 / Experion Holdings Ltd. (the "Corporation" or "Experion") (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) Canada's solution to craft cannabis supply and builder of premium cannabis brands including its sought after and popular brand Citizen Stash announced today that it will be reporting its fiscal year 2020 and fourth quarter financial results for the year ending November 30, 2020 after market close on...

Read more

Tetra Bio-Pharma Receives Compliant Rating on Inspection from Health Canada

March 18, 2021 2:00 AM

Quantum Pharma Inc. is a contract facility operated by Tetra Bio-Pharma Inc Quantum Pharma Inc. receives a Notice of Compliant rated inspection OTTAWA, ON / ACCESSWIRE / March 18, 2021 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP)(OTCQB:TBPMF)(FRA:JAM1), a biopharmaceutical pioneer in immunomodulator drug discovery and development announce that its contract manufacturing facility, Quantum Pharma Inc., received a notice...

Read more

Enveric Biosciences Discusses Acquisition of Exclusive License from Diverse Biotech and Value Catalysts Moving Forward in New Video Interview on SNN Network

March 17, 2021 11:00 AM

LOS ANGELES, CA / ACCESSWIRE / March 17, 2021 / SNN Network, The Official Small-, Micro- and Nano-Cap News Source™, today published a new Video Interview with David Johnson, Chairman, and CEO of Enveric Biosciences (NASDAQ:ENVB), a patient-first biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, according to the company's website (see here: www.enveric.com). Click the following...

Read more

Protean BioDiagnostics to Present at AACR 2021 Annual Meeting

March 17, 2021 10:00 AM

ORLANDO, FL / ACCESSWIRE / March 17, 2021 / Protean BioDiagnostics Inc. ("Protean"), a disruptive biotechnology company developing and commercializing novel cancer diagnostics supporting precision oncology, is pleased to announce that its below-referenced abstract has been accepted for presentation at the upcoming American Association for Cancer Research (AACR) Virtual Annual Meeting, April 10-15 and May 17-21, 2021. "Targeted therapy for...

Read more

Xenetic Biosciences, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results

March 17, 2021 8:00 AM

Driving development of XCART™ platform and leveraging academic collaborations through preclinical development Recent clinical, regulatory and commercial advancements from licensing partners leveraging PolyXen® platform technology FRAMINGHAM, MA / ACCESSWIRE / March 17, 2021 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing XCART™, a personalized CAR T platform...

Read more

Helix BioPharma Corp. Announces Fiscal Second Quarter 2021 Results

March 16, 2021 5:00 PM

RICHMOND HILL, ON / ACCESSWIRE / March 16, 2021 / Helix BioPharma Corp. (TSX:"HBP"), an immuno-oncology company developing drug candidates for the prevention and treatment of cancer, today announced its financial results for the fiscal second quarter ended January 31, 2021. OVERVIEW The Company reported a net loss and total comprehensive loss of $2,492,000 and $2,714,000 for the three and six-month periods ended January 31, 2021. For...

Read more

Dyadic to Report Fourth Quarter and Full Year 2020 Financial Results

March 16, 2021 4:00 PM

JUPITER, FL / ACCESSWIRE / March 16, 2021 / Dyadic International, Inc. ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ:DYAI), a global biotechnology company focused on further improving, applying and deploying its proprietary C1-cell protein production platform to accelerate development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales, today announced that it will report its...

Read more

Lexaria's Antiviral Drug Evaluation Program Progressing

March 16, 2021 7:00 AM

Two of the four planned studies progressing to examine DehydraTECH™ with antivirals targeting SARS-CoV-2 / COVID-19. KELOWNA, BC / ACCESSWIRE / March 16, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces extensive progress in two of the four planned antiviral drug studies in its 2021 applied research and development (R&D)...

Read more

CB Scientific, Inc. (CBSC) Distributor Mango Wellness Comes to an Agreement to Provide Services to Three Major Hospital Chains in Thailand

March 16, 2021 7:00 AM

Successful introductory product trials result in an agreement by three major hospital chains to use the my-Cam device ESCONDIDO, CA / ACCESSWIRE / March 16, 2021 / CB Scientific, Inc. (OTC PINK:CBSC) ("CBSC" or the "Company"), a provider of innovative products and services for the ambulatory noninvasive cardiac monitoring space, announces today the anticipated addition of three major hospital chains to use Remote Cardiac Monitoring Services...

Read more

Viewpoint Molecular Targeting(TM) Establishes Strategic Manufacturing Supply Agreement with Industry-Leader, SpectronRx, to Accelerate Build-Out of Ra-224/Pb-212 Generator (VMT-a-GEN) Production Facilities

March 15, 2021 10:00 AM

- SpectronRx is a well-established CDMO with a reputation of supplying high-quality, GMP/Pharmaceutical grade isotopes without impurities that meet FDA standards for radiopharmaceuticals - - Building out VMT-𝛼-GEN isotope generator facilities and scaling of the manufacturing processes for radionuclides are integral in advancing Viewpoint's development pipeline - - Viewpoint's proprietary VMT-𝛼-GEN isotope generator enables a nimble...

Read more